Nucleoside inhibitors of Zika virus

scientific article

Nucleoside inhibitors of Zika virus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/JIW226
P698PubMed publication ID27234417

P50authorMartin PalusQ59146848
Erik De ClercqQ13578863
Ernest A. GouldQ24701585
Maria João AlvesQ52804112
P2093author name stringRadim Nencka
Daniel Růžek
Luděk Eyer
Ivana Huvarová
P2860cites workMolecular targets for flavivirus drug discoveryQ21999123
Concurrent outbreaks of dengue, chikungunya and Zika virus infections – an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012–2014Q22330735
Zika Virus Associated with MicrocephalyQ22683189
Acute myelitis due to Zika virus infectionQ23014548
The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection ModelQ23309956
The Emerging Zika Virus Epidemic in the Americas: Research PrioritiesQ24247054
Zika Virus Associated with MeningoencephalitisQ24247064
Zika Virus as a Cause of Neurologic DisordersQ24261288
Nucleoside inhibitors of tick-borne encephalitis virusQ24276103
Novel approaches to flavivirus drug discoveryQ34206832
Antiviral agents acting as DNA or RNA chain terminatorsQ34892252
New developments in flavivirus drug discoveryQ38769771
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymeraseQ42984396
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectnucleosideQ28734
antiviral drugQ846227
Zika virusQ202864
P5008on focus list of Wikimedia projectWikiProject Zika CorpusQ54439832
P304page(s)707-11
P577publication date2016-05-27
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleNucleoside inhibitors of Zika virus
P478volume214

Reverse relations

cites work (P2860)
Q53682362A Review of the Ongoing Research on Zika Virus Treatment.
Q47280870A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity
Q38157419A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses
Q66680603Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells
Q27463110Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus
Q38156667Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives
Q51336416Adverse outcomes of pregnancy-associated Zika virus infection.
Q36147591An Approach for Zika Virus Inhibition Using Homology Structure of the Envelope Protein
Q28581011Analysis of Ribonucleotide 5’ -Triphosphate Analogs as Potential Inhibitors of Zika Virus RNA-dependent RNA Polymerase Using Non-Radioactive Polymerase Assays
Q53693795Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses.
Q47547159Blocking Zika virus vertical transmission
Q99603820Broad-spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View
Q29994527Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
Q49796493Characterisation of Zika virus infection in primary human astrocytes.
Q37677916Commentary: Teratogenic effects of the Zika virus and the role of the placenta
Q43046702Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro
Q58122069Complementary Mechanisms Potentially Involved in the Pathology of Zika Virus
Q86939020Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus
Q37698482Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5.
Q30145530De novo RNA synthesis catalyzed by the Zika Virus RNA polymerase domain
Q56342513Development and validation of a phenotypic high-content imaging assay for assessing the antiviral activity of small-molecule inhibitors targeting the Zika virus
Q92188514Development of Small-Molecule Inhibitors Against Zika Virus Infection
Q63246230Development of a fluorescence-based method for the rapid determination of Zika virus polymerase activity and the screening of antiviral drugs
Q28954597Epidemiology, Prevention, and Potential Future Treatments of Sexually Transmitted Zika Virus Infection
Q40080931Escape of tick-borne flavivirus from 2' -C-methylated nucleoside antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness
Q28804198Evaluation of Possible Consequences of Zika Virus Infection in the Developing Nervous System
Q33794343Global Alert: Zika Virus-an Emerging Arbovirus
Q90419101Importance of Zika Virus NS5 Protein for Viral Replication
Q95301704In vitro Studies on The Inhibition of Replication of Zika and Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus cervicornis
Q38158000Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice
Q61053965Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus
Q54256710Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
Q30145642Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika
Q47095447Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides
Q43039888RNA-dependent RNA polymerase: Addressing Zika outbreak by a phylogeny-based drug target study
Q58099567Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection
Q38156553Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
Q41925559Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference
Q38867867Structural basis of Zika virus methyltransferase inhibition by sinefungin
Q47555436Structural biology of Zika virus and other flaviviruses
Q48504896Structure and function of Zika virus NS5 protein: perspectives for drug design.
Q56353961The A-Z of Zika drug discovery
Q29051492The Race To Find Antivirals for Zika Virus
Q25707196The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication
Q28595139The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Q56000954The structural model of Zika virus RNA-dependent RNA polymerase in complex with RNA for rational design of novel nucleotide inhibitors
Q49215219The structure of the binary methyltransferase-SAH complex from Zika virus reveals a novel conformation for the mechanism of mRNA capping
Q93078517Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go
Q41918254Therapeutic Approaches for Zika Virus Infection of the Nervous System
Q65054977Using Macaques to Address Critical Questions in Zika Virus Research.
Q38158967Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication
Q26693468Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia
Q60919470Zika Virus: Origins, Pathological Action, and Treatment Strategies
Q40037723Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?
Q29647477Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review
Q55084405Zika vaccines and therapeutics: landscape analysis and challenges ahead.
Q50020968Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options.
Q28278045Zika virus: from pathogenesis to disease control

Search more.